home.social

#endometrialcancer — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #endometrialcancer, aggregated by home.social.

  1. BioNTech reports promising Phase II data for uterine cancer ADC

    Trastuzumab pamirtecan, an investigational HER2‑targeted antibody-drug conjugate developed by BioNTech and DualityBio, has met the primary efficacy endpoint…
    #Europe #EU #ADC #BioNTech #Clinicaltrials #DualityBIO #endometrialcancer #European #oncology #uterinecancer
    europesays.com/europe/11565/

  2. A Nurse’s Journey Through Endometrial Cancer and Life After Hysterectomy

    📰 Original title: My Doctor Took One Look At My Watermelon-Sized Tumor And Said 6 Words. He Couldn’t Have Been More Wrong.

    🤖 IA: It's clickbait ⚠️
    👥 Usuarios: It's clickbait ⚠️

    View full AI summary: killbait.com/en/a-nurses-journ

    #health #endometrialcancer #hysterectomy #cancerawareness

  3. This One Type Of Cancer Is Increasing In All Women, But One Group Is Particularly At Risk

    When you think of the most common gynecological cancer, you probably don’t think of uterine cancer, but this…
    #NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Health #Blackwomen #cervicalcancer #EbonyHoskins #EndometrialCancer #GettyImages #Hoskins #ovariancancer #uterinecancer
    newsbeep.com/us/45651/

  4. DATE: March 28, 2025 at 08:00AM
    SOURCE: BioWorld MedTech

    Direct article link at end of text block below.

    Acrivon narrows focus for ACR-368 in #endometrialcancer

    t.co/UcBD8f1Kxj

    #medtech #Acrivon

    Here are any URLs found in the article text:

    t.co/UcBD8f1Kxj

    #medtech

    Articles can be found by scrolling down the page at bioworld.com/topics/85-bioworl .

    -------------------------------------------------

    Private, vetted email list for mental health professionals: clinicians-exchange.org
    .
    NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
    .
    Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: nationalpsychologist.com
    .
    EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:
    subscribe-article-digests.clin
    .
    READ ONLINE: read-the-rss-mega-archive.clin
    .
    It's primitive... but it works... mostly...
    .
    -------------------------------------------------

    #healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor #hospital #medtech

  5. DATE: March 27, 2025 at 06:00PM
    SOURCE: BioWorld MedTech

    Direct article link at end of text block below.

    Acrivon narrows focus for ACR-368 in #endometrialcancer

    t.co/UcBD8f1cHL

    #medtech #Acrivon

    Here are any URLs found in the article text:

    t.co/UcBD8f1cHL

    #medtech

    Articles can be found by scrolling down the page at bioworld.com/topics/85-bioworl .

    -------------------------------------------------

    Private, vetted email list for mental health professionals: clinicians-exchange.org
    .
    NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
    .
    Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: nationalpsychologist.com
    .
    EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:
    subscribe-article-digests.clin
    .
    READ ONLINE: read-the-rss-mega-archive.clin
    .
    It's primitive... but it works... mostly...
    .
    -------------------------------------------------

    #healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor #hospital #medtech

  6. AstraZeneca’s Truqap flops in phase III triple-negative breast cancer trial—Merck's Keytruda snags 40th US indication, leaps ahead of GSK with broad endometrial cancer approval —Roche partners with RNA editing biotech Ascidian—bit.ly/w28kSd #astrazeneca #breastcancer #clinicaltrials #endometrialcancer #merck #fda #rna #roche #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  7. Keytruda strikes out again in endometrial cancer with phase III flop—Novo inks $600M deal with Metaphore to develop next-gen obesity drugs —Takeda Pharma to restructure after annual profit slump --bit.ly/w28kSd #merck #keytruda #endometrialcancer #clinicaltrials #novonordisk #obesity #drugdevelopment #takeda #restructuring #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  8. 8/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc #EndometrialCancer

    #CME🔗bit.ly/3hYxu3R

    🔴#PostTest Q4️⃣
    During treatment w pembro + lenva, pt develops grade 3 HTN
    🔴What is the most effective mgmt strategy for this patient? (CS = corticosteroid)

  9. 8/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc #EndometrialCancer

    #CME🔗bit.ly/3hYxu3R

    🔴#PostTest Q4️⃣
    During treatment w pembro + lenva, pt develops grade 3 HTN
    🔴What is the most effective mgmt strategy for this patient? (CS = corticosteroid)

  10. 6/#TumorBoardTuesday #BonumCE #GynCSM #EndometrialCancer
    #CME 🔗bit.ly/3hYxu3R

    🔴#PostTest Q 2️⃣
    📊During tx w pembro + lenva, pt develops grd 3 diarrhea
    🛑Lenva held
    💊Loperamide Rx
    Grade3️⃣diarrhea persists

    🔴Which is the appropriate next step for this pt?

  11. 6/#TumorBoardTuesday #BonumCE #GynCSM #EndometrialCancer
    #CME 🔗bit.ly/3hYxu3R

    🔴#PostTest Q 2️⃣
    📊During tx w pembro + lenva, pt develops grd 3 diarrhea
    🛑Lenva held
    💊Loperamide Rx
    Grade3️⃣diarrhea persists

    🔴Which is the appropriate next step for this pt?

  12. 3/#TumorBoardTuesday #gyncsm #OncTwitter

    🤔Missed the #EndometrialCancer #MedTweetorial earlier this wk?
    🤯Feeling left behind?

    Don't fret, it's here📍

    ---
    RT @BonumCe
    1/ #OncTwitter #TumorBoardTuesday
    #EndometrialCancer #MedTweetorial🧵
    w @DrMMurphy @MeganLeigh127 @TumorBoardTues

    🧬Tx response
    🧪Trial results
    🔬Tox for TKI-ICI

    🆓#CME 🔗 bit.ly/3VBGJEJ
    Supported by educational grants from Eisai & @Merck
    twitter.com/BonumCe/status/161

  13. 💥#EndometrialCancer TKI/IO safety data & AE mgmt webinar 💥┈┈┈ w @DrMMurphy & @drteplinsky ┈┈┈🔹#CME info 👉 bit.ly/3Vqtabi 👈 @BonumCe ┈┈┈🔸Supported by edu grants from Eisai & @Merck 🔹#TumorBoardTuesday #gyncsm #OncTwitter twitter.com/i/broadcasts/1yoJM

  14. 5...4...3...2...1...it's the final countdown
    ⏰30m warning
    🔥#EndometrialCancer #webinar w @DrMMurphy & @drteplinsky🔥

    👩‍🏫B4 we begin...👩🏻‍🏫
    ✅Answer #PreTest polls 👇
    🔁Retweet & tag colleagues

    #TumorBoardTuesday #OncTwitter #MedTwitter #GynCSM #gynonc

    ---
    RT @TumorBoardTues
    2/#TumorBoardTuesday #OncTwitter #GynCSM #gynonc
    #CME🔗bit.ly/3YRDkog

    🟢#PreTest Q 1️⃣
    📊Diarrhea, nausea, & vomiting are common GI toxicities associated w…
    twitter.com/TumorBoardTues/sta

  15. 5/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc #EndometrialCancer
    #CME 🔗bit.ly/3YRDkog

    🟢#PreTest Q 4️⃣
    📊During treatment w pembro + lenva, pt develops grade 3 HTN
    🟢What is the most effective mgmt strategy for this patient? (CS = corticosteroid)

  16. 5/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc #EndometrialCancer
    #CME 🔗bit.ly/3YRDkog

    🟢#PreTest Q 4️⃣
    📊During treatment w pembro + lenva, pt develops grade 3 HTN
    🟢What is the most effective mgmt strategy for this patient? (CS = corticosteroid)

  17. 5/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc #EndometrialCancer
    #CME 🔗bit.ly/3YRDkog

    🟢#PreTest Q 4️⃣
    📊During treatment w pembro + lenva, pt develops grade 3 HTN
    🟢What is the most effective mgmt strategy for this patient? (CS = corticosteroid)

  18. 3/#TumorBoardTuesday #GynCSM #EndometrialCancer
    #CME🔗bit.ly/3YRDkog

    🟢#PreTest Q 2️⃣
    📊During tx w pembro + lenvatinib, pt develops grade 3 diarrhea
    🛑Lenva held
    💊Loperamide Rx
    Grade3️⃣diarrhea persists

    🟢What is the next step for this pt?
    (cs=corticosteroid)

  19. 1/#TumorBoardTuesday #OncTwitter

    🗓️TODAY🗓 w @DrMMurphy & @drteplinsky
    🎥#EndometrialCancer - Mnging TKI/IO AEs

    #CMEℹ️ bit.ly/3Vqtabi
    Support by edu grants from Eisai & @Merck

    🚨Be ready @ 8p ET/5p PT
    ✅Answer #PreTest👇
    🔁RT & tag 🩺

    🟢Where r u in your career?

  20. 24/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc

    🏆#CME➡️ bit.ly/3jCyVFJ

    🔴Post Poll2️⃣
    🔴What is the most common grade 3 or higher toxicity associated w the combo of pembro & lenva in pts w #EndometrialCancer?

  21. 24/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc

    🏆#CME➡️ bit.ly/3jCyVFJ

    🔴Post Poll2️⃣
    🔴What is the most common grade 3 or higher toxicity associated w the combo of pembro & lenva in pts w #EndometrialCancer?

  22. 20/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc #EndometrialCancer

    🟢During treatment w pembro & lenva, pt develops frequent, loose, watery stools

    How could you quickly determine which drug is causing the diarrhea?

  23. 20/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc #EndometrialCancer

    🟢During treatment w pembro & lenva, pt develops frequent, loose, watery stools

    How could you quickly determine which drug is causing the diarrhea?

  24. 17/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc #EndometrialCancer

    45.6% pts ≥2 ⬇️lenva dose#KEYNOTE775
    🔸Often need new 30d dose pack b4 finishing current supply

    🆕Eisai dose exchange program - cover all indicated dose⬇️🔗bit.ly/3gYHvOd

  25. 17/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc #EndometrialCancer

    45.6% pts ≥2 ⬇️lenva dose#KEYNOTE775
    🔸Often need new 30d dose pack b4 finishing current supply

    🆕Eisai dose exchange program - cover all indicated dose⬇️🔗bit.ly/3gYHvOd

  26. 16/#TumorBoardTuesday #BonumCE #OncTwitter #gyncsm #gynonc #EndometrialCancer

    💊 Lenva dose mods = dose reduce⬇️or withhold🛑for more severe tox

    Recommended lenva starting ▶️dose adv EC: 20mg QD
    🥇1st dose⬇️14mg
    🥈2nd dose⬇️10mg
    🥉3rd dose⬇️8mg

  27. 16/#TumorBoardTuesday #BonumCE #OncTwitter #gyncsm #gynonc #EndometrialCancer

    💊 Lenva dose mods = dose reduce⬇️or withhold🛑for more severe tox

    Recommended lenva starting ▶️dose adv EC: 20mg QD
    🥇1st dose⬇️14mg
    🥈2nd dose⬇️10mg
    🥉3rd dose⬇️8mg

  28. 15/#TumorBoardTuesday #BonumCE #OncTwitter #gyncsm #gynonc #EndometrialCancer

    🟢During tx w/ pembro-lenva, a pt develops grade 3 HTN requiring reduction in lenva. Starting dose of lenva was 20mg.

    Which dose is recommended for lenva now?

  29. 15/#TumorBoardTuesday #BonumCE #OncTwitter #gyncsm #gynonc #EndometrialCancer

    🟢During tx w/ pembro-lenva, a pt develops grade 3 HTN requiring reduction in lenva. Starting dose of lenva was 20mg.

    Which dose is recommended for lenva now?

  30. 14/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc #EndometrialCancer

    🚨VEGFR TKI-related class tox e.g. HTN, proteinuria
    🗓Typ occur 1st few wks tx
    💊Dose-dependent
    🧮Managed w dose mods & supportive care (e.g. anti-hypertensive)

  31. 14/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc #EndometrialCancer

    🚨VEGFR TKI-related class tox e.g. HTN, proteinuria
    🗓Typ occur 1st few wks tx
    💊Dose-dependent
    🧮Managed w dose mods & supportive care (e.g. anti-hypertensive)

  32. 11/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc

    🟢What is the most common grade 3 or higher toxicity associated w/ the combination of pembro & lenva in pts w/ #EndometrialCancer?

  33. 11/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc

    🟢What is the most common grade 3 or higher toxicity associated w/ the combination of pembro & lenva in pts w/ #EndometrialCancer?

  34. 9/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc #EndometrialCancer

    ⚙️Lenva=multi🎯TKI (incl VEGFR)
    🛑Blocks angiogenic signaling
    VEGFR signals also have immunosuppressive role

    ⚙️Pembro=ICI
    💪Boosts anti-tumor immune response

    🔑Combo tx=synergistic anti-tumor activity

  35. 9/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc #EndometrialCancer

    ⚙️Lenva=multi🎯TKI (incl VEGFR)
    🛑Blocks angiogenic signaling
    VEGFR signals also have immunosuppressive role

    ⚙️Pembro=ICI
    💪Boosts anti-tumor immune response

    🔑Combo tx=synergistic anti-tumor activity

  36. 8/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc #EndometrialCancer

    Pivotal trials leading to FDA approval in 2L met MSI-H/dMMR #EndometrialCarcinoma

    🔸Pembro: #KEYNOTE158 (phase 2)
    🔹Dostarlimab: #GARNET (phase 1)

    🔑Efficacy & safety data 📷👇

  37. 8/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc #EndometrialCancer

    Pivotal trials leading to FDA approval in 2L met MSI-H/dMMR #EndometrialCarcinoma

    🔸Pembro: #KEYNOTE158 (phase 2)
    🔹Dostarlimab: #GARNET (phase 1)

    🔑Efficacy & safety data 📷👇

  38. 7/#TumorBoardTuesday #BonumCE #OncTwitter #gyncsm #gynonc

    🧬Faulty DNA repair (dMMR/MSI-H)➡️high tumor mutation burden
    ➡️more tumor neoantigens
    ➡️sensitivity to ICI

    💎Two FDA approved ICIs in dMMR/MSI-H #EndometrialCancer:
    🔹Pembro (PD-1 mAb)
    🔹Dostarlimab (PD-1 mAb)

  39. 7/#TumorBoardTuesday #BonumCE #OncTwitter #gyncsm #gynonc

    🧬Faulty DNA repair (dMMR/MSI-H)➡️high tumor mutation burden
    ➡️more tumor neoantigens
    ➡️sensitivity to ICI

    💎Two FDA approved ICIs in dMMR/MSI-H #EndometrialCancer:
    🔹Pembro (PD-1 mAb)
    🔹Dostarlimab (PD-1 mAb)

  40. 6/#TumorBoardTuesday #BonumCE #OncTwitter #gyncsm #gynonc

    After progression on chemotx, tx for metastatic #EndometrialCancer is influenced by tumor molecular subtype

    🧬Cancer Genome Atlas ID’d 4️⃣ mol subclasses…
    1️⃣POLE ultramutated
    2️⃣dMMR/MSI-H
    3️⃣Copy # low
    4️⃣Copy # high